Pfizer ROI - Return on Investment 2010-2025 | PFE

Pfizer return on investment for the quarter ending March 31, 2025 was 5.34.

  • Pfizer average return on investment for 2024 was 1.58, a 86.6% increase from 2023.
  • Pfizer average return on investment for 2023 was 11.79, a 51.68% decline from 2022.
  • Pfizer average return on investment for 2022 was 24.4, a 61.7% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Pfizer ROI - Return on Investment 2010-2025 | PFE

  • Pfizer average return on investment for 2024 was 1.58, a 86.6% increase from 2023.
  • Pfizer average return on investment for 2023 was 11.79, a 51.68% decline from 2022.
  • Pfizer average return on investment for 2022 was 24.4, a 61.7% decline from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.